Skip to main content
AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.47%0700.HK-6.19%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.76%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.70%0857.HK-1.46%UNH-10.21%1288.HK-1.64%PM-0.85%0005.HK-2.09%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.69%AUDUSD-1.56%EURAUD+1.01%AUDCHF-0.99%AUDCAD-0.99%GBPAUD+0.93%AUDNZD-0.88%NZDJPY-0.82%GBPJPY-0.76%CADJPY-0.71%EURJPY-0.71%CHFJPY-0.70%NZDUSD-0.67%AUDSGD-0.62%GBPUSD-0.61%USDCHF+0.60%USDCAD+0.58%AUDDKK-0.56%EURUSD-0.56%USDZAR+0.44%GBPTRY+0.41%USDMXN+0.41%AUDNOK-0.37%USDTHB+0.35%NZDMXN+0.32%GBPHKD+0.32%EURZAR+0.31%USDNOK+0.30%GBPMXN-0.28%GBPZAR+0.28%CHFNOK+0.26%NOKJPY-0.24%USDTRY+0.21%USDSEK+0.19%EURNOK+0.19%USDPLN+0.17%USDILS+0.16%USDJPY-0.15%EURCNH-0.15%CHFSEK+0.14%EURHKD-0.13%USDCNH-0.12%NZDCAD-0.12%USDDKK+0.12%EURNZD+0.11%NZDCHF-0.11%GBPSGD-0.09%PLNJPY-0.09%EURSEK+0.08%EURGBP+0.06%GBPNZD+0.06%USDSGD+0.06%EURSGD-0.06%GBPCAD-0.05%EURPLN+0.05%EURCZK+0.04%EURCHF+0.04%USDCOP-0.04%SGDJPY+0.02%GBPCHF-0.02%EURCAD+0.02%USDHKD-0.01%CADCHF+0.01%NZDSGD-0.01%CHFSGD0.00%EURDKK0.00%XPTUSD-1.14%XAGUSD-0.95%GAGUSD-0.95%XAUUSD-0.64%GAUUSD-0.64%HG1-0.53%W1-0.47%XNGUSD-0.44%C1-0.29%UKOIL+0.28%S1-0.15%USOIL+0.05%BTCUSD-3.70%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.67%ZECUSDT-7.39%XMRUSDT-2.17%DOGEUSD+55.95%LINKUSD-3.57%XLMUSD-3.94%BCHUSDT-3.64%LTCUSD+47.50%UNIUSD-3.19%SUIUSD-3.36%TONUSD+59.18%HBARUSDT-5.48%TAOUSDT-3.60%AAVEUSD-3.76%ONDOUSDT-5.67%ICPUSDT-2.09%DOTUSDT-4.17%WLDUSDT-3.94%ARBUSDT-5.98%ATOMUSDT-2.61%INJUSDT-8.15%STXUSDT-3.46%PYTHUSDT-1.58%TIAUSDT-3.65%FETUSDT-4.91%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.62%OPUSDT-3.90%IOTAUSDT-2.72%POLUSDT-2.17%WIFUSDT-2.98%AXSUSDT-3.20%EOSUSDT-4.53%IMXUSDT-3.86%FARTCOINUSDT-7.06%GALAUSDT-2.38%DYDXUSDT-3.30%ORDIUSDT-2.78%NOTUSDT-2.34%RONINUSDT-2.92%AAPL+0.64%MSFT+1.07%NVDA+0.64%GOOGL+0.80%AMZN+1.46%SPCX+1.27%TSM+0.81%AVGO+3.64%META+0.81%TSLA+0.74%LLY-2.33%WMT-0.13%AMD+5.31%SKHY-0.11%JPM-1.77%BRK-B-2.07%MU+1.55%V-0.37%JNJ-2.15%XOM-3.97%MA-0.37%ASMLa+1.94%ABBV-2.33%COST-1.21%1398.HK-0.47%0700.HK-6.19%KO-0.71%CVX-4.74%PG-0.83%CSCO+2.18%0939.HK-0.05%ORCL-0.97%3988.HK-0.76%GE+0.52%BAC-1.07%HD-0.40%1816.HK-26.70%0857.HK-1.46%UNH-10.21%1288.HK-1.64%PM-0.85%0005.HK-2.09%NVS-2.46%HSBA.L-2.00%INTC-0.91%MS-1.29%AMAT+0.88%AP2d+2.23%AZN-1.93%TXN-1.16%AUDJPY-1.69%AUDUSD-1.56%EURAUD+1.01%AUDCHF-0.99%AUDCAD-0.99%GBPAUD+0.93%AUDNZD-0.88%NZDJPY-0.82%GBPJPY-0.76%CADJPY-0.71%EURJPY-0.71%CHFJPY-0.70%NZDUSD-0.67%AUDSGD-0.62%GBPUSD-0.61%USDCHF+0.60%USDCAD+0.58%AUDDKK-0.56%EURUSD-0.56%USDZAR+0.44%GBPTRY+0.41%USDMXN+0.41%AUDNOK-0.37%USDTHB+0.35%NZDMXN+0.32%GBPHKD+0.32%EURZAR+0.31%USDNOK+0.30%GBPMXN-0.28%GBPZAR+0.28%CHFNOK+0.26%NOKJPY-0.24%USDTRY+0.21%USDSEK+0.19%EURNOK+0.19%USDPLN+0.17%USDILS+0.16%USDJPY-0.15%EURCNH-0.15%CHFSEK+0.14%EURHKD-0.13%USDCNH-0.12%NZDCAD-0.12%USDDKK+0.12%EURNZD+0.11%NZDCHF-0.11%GBPSGD-0.09%PLNJPY-0.09%EURSEK+0.08%EURGBP+0.06%GBPNZD+0.06%USDSGD+0.06%EURSGD-0.06%GBPCAD-0.05%EURPLN+0.05%EURCZK+0.04%EURCHF+0.04%USDCOP-0.04%SGDJPY+0.02%GBPCHF-0.02%EURCAD+0.02%USDHKD-0.01%CADCHF+0.01%NZDSGD-0.01%CHFSGD0.00%EURDKK0.00%XPTUSD-1.14%XAGUSD-0.95%GAGUSD-0.95%XAUUSD-0.64%GAUUSD-0.64%HG1-0.53%W1-0.47%XNGUSD-0.44%C1-0.29%UKOIL+0.28%S1-0.15%USOIL+0.05%BTCUSD-3.70%ETHUSD+57.77%USDTUSD-0.01%XRPUSD+52.58%SOLUSD+57.55%TRXUSDT+0.67%ZECUSDT-7.39%XMRUSDT-2.17%DOGEUSD+55.95%LINKUSD-3.57%XLMUSD-3.94%BCHUSDT-3.64%LTCUSD+47.50%UNIUSD-3.19%SUIUSD-3.36%TONUSD+59.18%HBARUSDT-5.48%TAOUSDT-3.60%AAVEUSD-3.76%ONDOUSDT-5.67%ICPUSDT-2.09%DOTUSDT-4.17%WLDUSDT-3.94%ARBUSDT-5.98%ATOMUSDT-2.61%INJUSDT-8.15%STXUSDT-3.46%PYTHUSDT-1.58%TIAUSDT-3.65%FETUSDT-4.91%JUPUSDT+0.25%SEIUSDT-4.48%GRTUSDT-3.62%OPUSDT-3.90%IOTAUSDT-2.72%POLUSDT-2.17%WIFUSDT-2.98%AXSUSDT-3.20%EOSUSDT-4.53%IMXUSDT-3.86%FARTCOINUSDT-7.06%GALAUSDT-2.38%DYDXUSDT-3.30%ORDIUSDT-2.78%NOTUSDT-2.34%RONINUSDT-2.92%
CT

Celldex Therapeutics, Inc. (CLDX)

NASDAQ • Healthcare

$27.55
-$0.48 (-1.7%)
Market closed

Last close at November 18, 2026 at 21:00 UTC

Open$27.99
Day Range$27.45 - $28.65
Avg. Volume (3M)863.5K
Market Cap$2.1B
52 Week Range
$22.33$45.14

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$112K
Net Income (TTM)
-$309.1M
EPS (TTM)
-$4.31
ROA (TTM)
-42.84%
Current Ratio
10.97

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-2.9%Q2 2026-$1.18
+11.3%Q3 2026-$0.94
+5.9%Q4 2026-$0.96

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +5.9%

Celldex Therapeutics’ earnings for the third fiscal quarter of 2026, reported November 5, 2026, topped consensus on EPS in preliminary results, with EPS of -$0.96 topping the -$1.02 estimate by $0.06. The quarter still posted a GAAP net loss, with net income of roughly -$75.6 million, widening about 13% year over year from roughly -$67.0 million, as the antibody-based biotechnology company continues to advance pipeline programs including CDX-0159, CDX-1140, and CDX-527. Cash burn remained evident in the period, with negative operating cash flow of about -$65.0 million.

View full earnings history

About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. develops antibody-based treatments as a biotechnology company in the healthcare sector and trades on the NASDAQ under CLDX. Founded in 1983, Celldex is a small-cap drug developer focused on monoclonal and bispecific antibodies aimed at inflammatory diseases and cancers.

Name
Celldex Therapeutics, Inc.
CEO
Anthony S. Marucci
Industry
Healthcare
Year Founded
1983
Employees
198

Today's Snapshot

AI-generated

CLDX closed 1.8% lower at 27.55, in line with a weaker sector.

Trading Volume

Below 10d avg (849.0K)

679.5K

vs S&P 500 Today

Underperforming Market

-1.49%

Updated: November 18, 2026 at 21:27 UTC

Technical Indicators

1 Buy1 Neutral6 Sell
CLDX is under downward pressure with multiple momentum signals and moving averages aligned bearish. The MACD and CCI are negative, momentum is weak, and the stock trades below its short-, medium- and long-term averages, underscoring broad technical weakness. On-balance volume is negative, lending volume-based confirmation to the decline, while ADX indicates only a modest trend reading and ATR shows moderate intraday range; the price sits at the lower Bollinger band and below the classic pivot, highlighting the current bias. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$28.86 - $32.67
    Sell
  • RSI (14)38.45
    Neutral
  • Stochastic %K (14, 3, 3)11.66
    Buy
  • MACD Level (12, 26)-0.76
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.